Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary

Table 4 Factors associated with glycemic goal – logistic regression analyses

Variable	Odds ratio	95% Wald confidence limits		Pr > ChiSq
BMI at baseline^‡	0.92	0.86	0.98	0.009
H/O Macro-vascular complications (Yes)^¥	1.45	0.82	2.57	0.205
Females^¥	0.72	0.41	1.29	0.272
Absence of Regular Physical Activity^¥	0.77	0.41	1.47	0.433
Zero alcohol consumption^¥	0.93	0.51	1.71	0.815
Zero cigarette consumption^¥	1.14	0.64	2.04	0.649
Number of Co-medications	0.87	0.58	1.29	0.483
MF + TZD at index date^¥	1.53	0.81	2.89	0.195
Family history of diabetes^¥	0.70	0.41	1.22	0.209
(Probability modeled is Goal = Yes. N = 304)

^† MF: Metformin
** TZD: Thiazolidinedione
^‡ Body Mass Index
^¥ (Reference categories: absence of macro event, male, some physical activity, occasionally/daily drinker, current/past smoker, Metformin + Sulfonylurea at baseline, no family history of diabetes)

ISSN: 1477-7525